Gaois

This is a static copy of data that is exported from IATE on an occasional basis. It should not be assumed that information provided about an entry here will always correspond to the current version of the entry in IATE. That current version can be checked by clicking on the link on the upper right hand side of each entry. More information »

2 results

  2. SOCIAL QUESTIONS|health|pharmaceutical industry|pharmaceutical product|medicament|antibiotic · PRODUCTION, TECHNOLOGY AND RESEARCH|research and intellectual property|research

    #668782

    IATE #3638816
    luaíocht iontrála sa mhargadh Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Comment <<<_not_supplied_>>>
    Markteintrittsprämie | pauschale Markteintrittsprämie
    de
    market entry reward | lump-sum market entry reward
    en
    Definition incentive designed to pay a fixed sum over a number of years for the commercialisation of an antibiotic that meets a predefined public health need, as long as the company meets the negotiated stipulations regarding access and stewardship Reference "Christine Årdal, Yohann Lacotte, and Marie-Cécile Ploy, on behalf of the European Union Joint Action on Antimicrobial Resistance and Healthcare- Associated Infections (EU-JAMRAI). 'Financing Pull Mechanisms for Antibiotic-Related Innovation: Opportunities for Europe' (7.9.2023). Clinical Infectious Diseases Viewpoints 2020:71 (15 October)"
    prime d’entrée sur le marché | prime forfaitaire d’entrée sur le marché | récompense lors de l’entrée sur le marché
    fr
    Definition série de paiements effectués à un développeur ayant obtenu l’approbation réglementaire d’un antibiotique répondant à certains critères prédéfinis, à condition qu'il respecte les dispositions négociées en matière d’accès et de gestion Reference "COM-FR, d'après :- Communication de la Commission - Réforme de la législation pharmaceutique et mesures de lutte contre la résistance aux antimicrobiens, COM(2023) 190 final- European Union Joint Action on Antimicrobial Resistance and Healthcare- Associated Infections (EU-JAMRAI) > Financing Pull Mechanisms for Antibiotic-Related Innovation: Opportunities for Europe (1.6.2023), Clinical Infectious Diseases Viewpoints (2020) (uniquement en anglais)"